Standard BioTools Inc（LAB）價格預測

$0.616

+0.005 (+0.85%)收盤時

價格預測

1-Day Price Prediction

+1.01%

1-Week Prediction

+4.62%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

LAB 相似圖表分析預測

Alphio's LAB stock price prediction model matches the current Standard BioTools Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.62 (+1.01%). The 1-week path is $0.64 (+4.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Standard BioTools Inc 股票嗎？

Standard BioTools Inc (LAB) appears to be a good buy right now, primarily due to its current price of 0.6099, which is near its 52-week low of 0.59, indicating a potential for recovery. Additionally, the stock has a forward P/E ratio of 0, suggesting that it may be undervalued compared to its earnings potential. The recent merger with Treeline Biosciences is expected to enhance financial stability, providing over $900 million in cash to fund operations into 2029, which is a strong positive catalyst.

LAB 股價於 Wednesday 收在 $0.62，此前上漲 +0.85%

Standard BioTools Inc (LAB) last closed at $0.616, gaining +0.85%. These facts feed the 1-day and 1-week LAB price prediction above.

預測驅動因素

Standard BioTools Inc（LAB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 LAB 最接近的股票，依相似度排序。

MDLN

88.44%

+5.63%

BNS

88.11%

+8.29%

XYZ

87.94%

+15.54%

FLS

87.82%

+30.08%

KEY

87.54%

+11.20%

LAB 季節性分析

Historically the probability of a positive November return for LAB is 4.76%. January offers the highest probability of a positive month at 63.93%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…